NASDAQ OMX (NASDAQ:NDAQ) announced that Bactiguard Holding AB (short name: BACTI B), a Mid Cap company within the Health Care sector, has started trading of its shares on the main market of NASDAQ OMX Stockholm. Bactiguard is, including switches, the 15th company to list at NASDAQ OMX’s Nordic main markets in 2014 (NASDAQ OMX Stockholm; Helsinki; Copenhagen; and Iceland).
Bactiguard is a Swedish medtech company with a mission of preventing healthcare associated infections, reducing the use of antibiotics and saving lives by developing and supplying infection prevention solutions for the healthcare industry. The company’s patented coating prevents healthcare associated infections by reducing bacterial adhesion and growth on medical devices. Bactiguard®-coated urinary catheters are market leading in the US and Japan, and in recent years the company has developed its own product portfolio of coated catheters for the urinary and respiratory tract and the blood stream. Bactiguard is currently in a strong expansion phase, focused on new markets in the EU, Middle East, Asia and South America. The company reported sales of approximately SEK 130 million in 2013, has 60 employees, headquarters in Stockholm and production facilities in Markaryd and Malaysia.
“Today’s listing is an important milestone for Bactiguard and an important step in creating a long-term platform for the company’s continued development,” said Johan Rugfelt, CEO of Bactiguard. “Our listing will contribute positively to the company’s growth opportunities and make Bactiguard’s efforts to prevent healthcare-associated infections better known among customers, the media and investors.”
”We welcome Bactiguard to our main market and congratulate them on its successful IPO,” said Adam Kostyal, Senior Vice President at NASDAQ OMX. “Bactiguard presents a great example of the type of innovative healthcare companies that opt for a listing with NASDAQ OMX and we look forward to celebrating more milestones with them in the years to come.”